Ronald Kahn

Ronald Kahn

doctorMale0.0Global Dominance: 0.00%

Ronald Kahn is a prominent professor of medicine at Harvard University and the academic director of the Joslin Diabetes Center. He has noted that many of his patients are hesitant to use injectable diabetes treatments, emphasizing that an oral medication like orforglipron would likely be preferred by the majority.

Power0
Reach0
Collect

Not in the pool (under ¢1).

Recent news mentions

Ronald Kahn, a professor of medicine at Harvard University, noted that many of his patients are reluctant to use injectable medications like Ozempic or Mounjaro.

Pílula diária de GLP-1, classe do Ozempic, apresenta dados animadores de controle do peso e diabetes
O Estado de S. Paulo (Estadão)·LiechtensteinLiechtenstein· 2025-04-17
6.0